155 related articles for article (PubMed ID: 19152176)
1. Oral contraceptive pill containing drospirenone and the professional voice: an electrolaryngographic analysis.
Lã FM; Howard DM; Ledger W; Davidson JW; Jones G
Logoped Phoniatr Vocol; 2009; 34(1):11-9. PubMed ID: 19152176
[TBL] [Abstract][Full Text] [Related]
2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
3. Response of the female vocal quality and resonance in professional voice users taking oral contraceptive pills: a multiparameter approach.
Van Lierde KM; Claeys S; De Bodt M; Van Cauwenberge P
Laryngoscope; 2006 Oct; 116(10):1894-8. PubMed ID: 17003704
[TBL] [Abstract][Full Text] [Related]
4. The effects of a third generation combined oral contraceptive pill on the classical singing voice.
Lã FM; Ledger WL; Davidson JW; Howard DM; Jones GL
J Voice; 2007 Nov; 21(6):754-61. PubMed ID: 16887327
[TBL] [Abstract][Full Text] [Related]
5. Birth control pills and nonprofessional voice: acoustic analyses.
Amir O; Biron-Shental T; Shabtai E
J Speech Lang Hear Res; 2006 Oct; 49(5):1114-26. PubMed ID: 17077219
[TBL] [Abstract][Full Text] [Related]
6. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
Duijkers IJ; Klipping C; Grob P; Korver T
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):314-25. PubMed ID: 20695770
[TBL] [Abstract][Full Text] [Related]
7. Effects of the menstrual cycle and oral contraception on singers' pitch control.
Lã FM; Sundberg J; Howard DM; Sa-Couto P; Freitas A
J Speech Lang Hear Res; 2012 Feb; 55(1):247-61. PubMed ID: 22199189
[TBL] [Abstract][Full Text] [Related]
8. Association between birth control pills and voice quality.
Amir O; Kishon-Rabin L
Laryngoscope; 2004 Jun; 114(6):1021-6. PubMed ID: 15179206
[TBL] [Abstract][Full Text] [Related]
9. Vocal pitch levels during connected speech associated with oral contraceptive use.
Gorham-Rowan M; Langford A; Corrigan K; Snyder B
J Obstet Gynaecol; 2004 Apr; 24(3):284-6. PubMed ID: 15203628
[TBL] [Abstract][Full Text] [Related]
10. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
Oelkers W
Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():17-24. PubMed ID: 11246598
[TBL] [Abstract][Full Text] [Related]
11. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
[TBL] [Abstract][Full Text] [Related]
12. Different oral contraceptives and voice quality--an observational study.
Amir O; Biron-Shental T; Tzenker O; Barer T
Contraception; 2005 May; 71(5):348-52. PubMed ID: 15854635
[TBL] [Abstract][Full Text] [Related]
13. The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.
Fruzzetti F; Lello S; Lazzarini V; Fratta S; Orrù M; Sorge R; Minerba L; Ricci C; Genazzani AR; Melis GB; Paoletti AM
Contraception; 2007 Mar; 75(3):199-203. PubMed ID: 17303489
[TBL] [Abstract][Full Text] [Related]
14. Fundamental Frequency Variations Across the Menstrual Cycle and the Use of an Oral Contraceptive Pill.
Lã FMB; Polo N
J Speech Lang Hear Res; 2020 Apr; 63(4):1033-1043. PubMed ID: 32293943
[TBL] [Abstract][Full Text] [Related]
15. A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.
Endrikat J; Sandri M; Gerlinger C; Rübig A; Schmidt W; Fortier M
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):220-8. PubMed ID: 17763260
[TBL] [Abstract][Full Text] [Related]
16. Does oral contraceptive use affect maximum force production in women?
Elliott KJ; Cable NT; Reilly T
Br J Sports Med; 2005 Jan; 39(1):15-9. PubMed ID: 15618333
[TBL] [Abstract][Full Text] [Related]
17. Perceived effects of the menstrual cycle on young female singers in the Western classical tradition.
Ryan M; Kenny DT
J Voice; 2009 Jan; 23(1):99-108. PubMed ID: 17658719
[TBL] [Abstract][Full Text] [Related]
18. Do oral contraceptives improve vocal quality? Limited trial on low-dose formulations.
Amir O; Biron-Shental T; Muchnik C; Kishon-Rabin L
Obstet Gynecol; 2003 Apr; 101(4):773-7. PubMed ID: 12681885
[TBL] [Abstract][Full Text] [Related]
19. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
Klipping C; Duijkers I; Trummer D; Marr J
Contraception; 2008 Jul; 78(1):16-25. PubMed ID: 18555813
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fundamental voice frequency between menopausal women and women at menacme.
Mendes-Laureano J; Sá MF; Ferriani RA; Reis RM; Aguiar-Ricz LN; Valera FC; Küpper DS; Romão GS
Maturitas; 2006 Sep; 55(2):195-9. PubMed ID: 16580156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
